Microbiology Testing Market: By Product Type (Instruments, Chemicals & Reagents, Consumables & Accessories, Others), By Application (Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Bloodstream Infections, Sexually Trasnsmitted Infections, Others), By End-User (Hospital Based Laboratories, Independent Laboratories, Acadamics & Research Institutes, Others) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Microbiology Testing Market size was valued at USD 3,913.6 Million in 2022 and is poised to grow at a significant CAGR of 10.6% over 2023-2029. Microbiology testing is an analytical technique utilized to determine the number of microorganisms in psoriasis biologicals samples, food, beverages, and environmental samples. The microbiology testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify microbes. The Chemicals & Reagents segment anticipated to grow at significant CAGR over the forecast years owing to the wide range of chemical reagent uses and research activities Constant advancements and development in technologies such as bio-therapeutics, cell culture, and recombinant DNA technology, which have allowed the manufacturers of a wide range of vital therapeutic agents, also fuel the demand for laboratory chemical reagents. Furthermore, rising demand from the biotechnology industry may drive market expansion in the next years. The market for protein synthesis and DNA sequencing reagents has grown considerably in recent years. Technological improvements in microbiology testing, increased occurrences of infectious illnesses and epidemic outbreaks such as COVID 19, rising healthcare spending, and expanding private-public financing for infectious disease research are driving the growth of the microbiology testing market.

Microbiology Testing Market Key Developments:
In February2020, QIAGEN partnered with Nigeria’s National Tuberculosis & Leprosy Control Program (NTBLCP) to adopt the World Health Organization (WHO) guidelines and guide healthcare professionals in dealing with latent TB
In July 2020, bioMérieux launched BIOFIRE MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry. The new BIOFIRE MYCOPLASMA test, which is available in the United States, will be launched in some countries in Europe and the Asia-Pacific region in the coming months.

Microbiology Testing Market Summary

Study Period

2023 – 2029

Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Microbiology Testing Market Dynamics

According to the WHO, three infectious diseases, including lower respiratory infections, diarrheal diseases, and TB, were among the top 10 causes of mortality globally in 2016. As a result, the increased frequency and incidence of infectious diseases drives the need for microbiological testing, resulting in worldwide market growth. Furthermore, the rising number of COVID-19 cases contributes to the market's expansion. Growing government and private funds and support for research and development further drive the growth of the market. For instance, the Department of Science and Technology (DST), India, announced funding of approximately USD 26.42 million to many scientific institutions, startups, and industries to build innovative solutions to fight the COVID-19 pandemic on 8 April 2020.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Microbiology Testing Market Segmentation

By Product Type
  • Instruments
  • Chemicals & Reagents
  • Consumables & Accessories
  • Others
By Application
  • Gastrointestinal Infections
  • Respiratory Infections
  • Urinary Tract Infections
  • Bloodstream Infections
  • Sexually Transmitted Infections
  • Others
By End User
  • Hospital Based Laboratories
  • Independent Laboratories
  • Academics & Research Institutes
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA


Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • bioMérieux SA (France)
  • Danaher. (US)
  • BD (US)
  • Abbott (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bruker (US)
  • Hologic, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • QIAGEN (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Merck KGaA (Germany)
  • 3M (US)